Apixaban, sold under the brand name Eliquis, is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with... 23 KB (1,889 words) - 02:56, 7 March 2024 |
risk factors. For example, in a study examining the effect of the drug apixaban on the occurrence of thromboembolism, 8.8% of placebo-treated patients... 12 KB (1,664 words) - 08:11, 4 November 2023 |
Andexxa among others, is an antidote for the medications rivaroxaban and apixaban, when reversal of anticoagulation is needed due to uncontrolled bleeding... 14 KB (1,177 words) - 04:30, 31 March 2024 |
population and minor bleeding in 167 more people per 1000 population. Apixaban had no effect on mortality, recurrence of blood clots in blood vessels... 78 KB (8,726 words) - 15:18, 29 April 2024 |
anticoagulant drugs (DOACs, e.g. dabigatran, rivaroxaban, edoxaban, or apixaban) is recommended. If the patient is 'low risk' using the CHA2DS2-VASc score... 30 KB (2,887 words) - 03:43, 2 February 2024 |
Treatment Anticoagulants: edoxaban, tinzaparin, unfractionated heparin Medication apixaban, edoxaban, and rivaroxaban Deaths 100,000–300,000 each year... 21 KB (2,280 words) - 19:04, 6 March 2024 |